Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

Scanning electron microscopy revealed four distinct hair root shapes in alopecia areata, suggesting a less invasive diagnostic method.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

Alopecia areata patients may have higher blood pressure and blood sugar, indicating a future risk of metabolic issues.

A rare combination of hair loss and excessive fine hair growth was found in celiac disease patients.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Trichoscopy is essential for diagnosing and managing alopecia areata in children.

Alopecia areata is common in young males and linked to stress.

Both treatments for localized alopecia areata are equally effective.

Many children with alopecia areata also have other autoimmune diseases.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Scalp alopecia areata mostly affects young adult males, often starts suddenly, and usually presents as single, patchy lesions.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.